Literature DB >> 28655509

Filgotinib in Crohn's Disease: JAK Is Back.

Silvio Danese1, Gionata Fiorino2, Laurent Peyrin-Biroulet3.   

Abstract

Entities:  

Year:  2017        PMID: 28655509     DOI: 10.1053/j.gastro.2017.06.040

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  2 in total

Review 1.  Revisiting Inflammatory Bowel Disease: Pathology, Treatments, Challenges and Emerging Therapeutics Including Drug Leads from Natural Products.

Authors:  Karma Yeshi; Roland Ruscher; Luke Hunter; Norelle L Daly; Alex Loukas; Phurpa Wangchuk
Journal:  J Clin Med       Date:  2020-04-28       Impact factor: 4.241

2.  Influence of age and renal impairment on the steady state pharmacokinetics of filgotinib, a selective JAK1 inhibitor.

Authors:  Florence Namour; Liesbeth Fagard; Annegret Van der Aa; Pille Harrison; Yan Xin; Chantal Tasset
Journal:  Br J Clin Pharmacol       Date:  2018-10-04       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.